In this 7th episode of SOIC’s “20 Unique Businesses” series, we deep dive into Alphabet — one of the world’s most integrated and difficult-to-replicate AI businesses. This episode covers the 5 layers of the AI value chain, Google Search, YouTube, Google Cloud, Gemini AI, TPUs, AI monetization, business model, growth drivers, management quality, valuation, and key risks. We also explore why Alphabet continues to grow at scale despite rising AI competition from ChatGPT, Anthropic, and other AI models.

If you want to understand how global technology leaders compound for decades and identify the biggest beneficiaries of the AI revolution, this episode is worth your time.

This episode covers the 6th unique business in our 20 Unique Businesses series. We discuss a high-quality value-added manufacturing business that transformed from a commodity player into a speciality products leader with strong margins, pricing power, export strength, and consistent cash flow generation. The episode also covers business model, growth triggers, capex plans, competitive advantages, valuation, and key risk factors, along with how the company handled US tariff challenges while maintaining strong profitability.

If you want to understand how unique businesses create long-term wealth through value addition and strong execution, this episode is worth your time.

In this episode, we break down Nippon India Asset Management Company and the rapidly growing asset management industry in India. We explore its strong financials, market share gains, and ETF leadership, along with the mental model behind successful AMCs. The discussion covers business model, growth drivers like SIP and passive investing, product mix, and competitive positioning. We also evaluate key risks and valuation to understand whether this is a long-term compounder in the making.

If you want to understand how AMC businesses grow and how to identify high-quality compounders early, this episode is worth your time.

In this podcast, we sit down with Rajeev Mantri from Navam Capital to break down one of the most important themes for India’s future — deep tech investing.

We discuss what deep tech really means, how it is different from traditional businesses, and why it can drive India’s journey from a 4 trillion to a 10 trillion dollar economy. You will learn how venture capital works step by step, how investors evaluate startups, and how idea pipelines are built through networks, founders, and institutions.

We also cover real case studies like Ather Energy, Botlab Dynamics, and Unbox Robotics to understand how deep tech companies are built and scaled.

If you want to understand startup investing, deep tech opportunities, and where India is heading next, this episode gives you a complete 101.

In this episode, we break down Sai Life Sciences, the fourth company in our 20 Unique Businesses series, where we explore high-quality companies with strong competitive advantages.

Sai Life Sciences is a unique CRDMO player in the pharma sector that earns 100% of its revenue from global innovator companies like Pfizer and AbbVie.

We explain how the CDMO and CRO industry works, why integration from research to manufacturing is a powerful business model, and how this company stands out from others in the space.

We also cover industry growth, business segments, key molecules, growth triggers, and risks, giving you a clear and simple understanding of this business.

In this episode, we break down one of the most unique businesses in the world — ASML Holding, a company that sits at the heart of the global semiconductor industry.

We explore how a single machine worth $400 million powers modern technologies like AI, data centers, smartphones, and advanced chips. From understanding the semiconductor value chain to ASML’s monopoly position, we dive deep into what makes this business so powerful.

We also cover the company’s history, growth drivers driven by AI capex, strong financials, valuation framework, and the key risks involved.

If you want to understand how global technology actually works behind the scenes and how to analyze such businesses for long-term investing, this episode will give you a complete framework.

In this episode, we break down Gravita India — a fast-growing recycling company benefiting from strong industry tailwinds.

We explore how the recycling sector is evolving due to decarbonization, resource scarcity, and government regulations, and why this is creating a J-curve growth opportunity.

We also analyze Gravita’s business model, sourcing advantage, financial performance, and future growth triggers like capacity expansion and value-added products.

If you want to understand a unique manufacturing business with strong fundamentals and long-term potential, this episode gives you a complete, simple breakdown.

In this episode, we break down INOX India, a unique business with strong entry barriers and market leadership.

We explore how the company operates in the cryogenic equipment space, enabling the entire industrial gas ecosystem — from storage to transportation.

We also discuss its strong financials, high return ratios, and why this business is difficult to replicate.

Along with this, we cover key growth drivers like LNG, semiconductors, and space applications, and understand the risks and opportunities ahead.

In this episode, we break down a powerful stock market strategy using real data and backtesting.

We explore how key factors like PE ratio, Price-to-Book, and earnings growth impact Nifty returns, and why lower valuations often lead to better future returns.

We also look at the current market situation — where valuations are getting cheaper but earnings growth is slowing — and what that means for investors.

If you want to understand when to invest, how to think about market cycles, and how to build a strong long-term investing approach, this episode will give you a clear framework.

In this episode, we break down the entire healthcare and pharmaceutical industry — one of the most recession-proof sectors in the market.

We explore how the healthcare value chain works, from hospitals and domestic pharma to CDMO, diagnostics, API companies, and emerging segments like GLP-1 drugs and medical devices.

Along the way, we decode the unit economics of each segment, understand where the real money is made, and analyze 40+ companies across the healthcare space to identify the fastest-growing businesses.

If you want to understand healthcare as an investor — from basics to advanced insights — this episode gives you a complete framework.